| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 828,484 | $82,840,083.00 | 4.27% |
| U.S. Treasury 4.625% 11/15/2055 | Fixed Income | 34,387,000 | $32,839,585.00 | 1.69% |
| U.S. Treasury 4.625% 2/15/2046 | Fixed Income | 24,491,000 | $23,608,942.00 | 1.22% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 22,525,000 | $22,869,092.00 | 1.18% |
| Morgan Stanley 4.356% 10/22/2031 (USD-SOFR + 1.074% on 10/22/2030) | Fixed Income | 20,272,000 | $19,871,000.00 | 1.03% |
| U.S. Treasury 3.50% 3/15/2029 | Fixed Income | 19,791,300 | $19,620,446.00 | 1.01% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 15,727,000 | $15,820,670.00 | 0.82% |
| Bank of America Corp. 5.045% 2/6/2037 (USD-SOFR + 1.13% on 2/6/2036) | Fixed Income | 15,129,000 | $14,933,806.00 | 0.77% |
| Abbott Laboratories 4.65% 3/15/2036 | Fixed Income | 13,934,000 | $13,630,838.00 | 0.7% |
| JPMorgan Chase & Co. 4.81% 10/22/2036 (USD-SOFR + 1.19% on 10/22/2035) | Fixed Income | 13,885,000 | $13,486,945.00 | 0.7% |
| TREASURY NOTE 3.625% 02-28-31 | Fixed Income | 13,864,500 | $13,596,958.00 | 0.7% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 12,944,000 | $12,949,682.00 | 0.67% |
| Goldman Sachs Group, Inc. 4.939% 10/21/2036 (USD-SOFR + 1.33% on 10/21/2035) | Fixed Income | 13,284,000 | $12,869,260.00 | 0.66% |
| U.S. Treasury 3.875% 3/31/2031 | Fixed Income | 12,544,600 | $12,505,889.00 | 0.65% |
| PacifiCorp 5.80% 4/15/2036 | Fixed Income | 12,266,000 | $12,369,341.00 | 0.64% |